XTLB is XTL Biopharmaceuticals Ltd. American Depositary Shares (Healthcare) — a non-dividend-paying stock. Trading at $2.53. Market cap: $6M.
Stock snapshot
| Price | $2.53 |
| Market cap | $6M |
| Sector | Healthcare |
| Exchange | XNAS |
| Pays dividend | No |
About XTLB
XTL Biopharmaceuticals Ltd is an intellectual property-based company focused on the development, management, and commercialization of intellectual property. The Company is engaged in biotechnology through its subsidiary Psyga Bio and in the biopharmaceutical industry with hCDR1, a novel compound working via a novel mechanism of action for the treatment of Systemic Lupus Erythematosus (SLE) and a potential treatment for Sjogren's syndrome (SS). It focuses on the acquisition and development of proprietary products and late-stage pharmaceutical product candidates for the treatment of unmet clinical needs.
Related non-dividend companies
Other non-dividend stocks investors research alongside XTLB. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is XTLB's current stock price?
XTLB (XTL Biopharmaceuticals Ltd. American Depositary Shares) is currently trading at $2.53.
Does XTLB pay a dividend?
XTLB (XTL Biopharmaceuticals Ltd. American Depositary Shares) does not currently pay a regular dividend.
Track XTLB in DiviDrip
Add XTLB to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search XTLB and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.